Occult primary breast cancer, i.e., isolated axillary adenocarcinoma withou
t detectable tumor in the breast by either physical exam or mammography, re
presents up to 1% of operable breast cancer. Modified radical mastectomy (M
RM) is generally the accepted treatment for this condition although tumor i
s identified in only two-thirds of mastectomy specimens. Breast magnetic re
sonance imaging (MRI) can identify occult breast carcinoma and may direct t
herapy. This study examined the ability of breast MRI to detect occult brea
st cancer and to facilitate breast conservation therapy.
Methods: Forty women with biopsy-proven metastatic adenocarcinoma to an axi
llary lymph node and no evidence of primary cancer were studied. All patien
ts had a physical examination, mammography, and MRI of the breast. Using a
dedicated breast coil, MRI imaging was performed with and without gadoliniu
m enhancement. Positive MRT scans were compared with histopathologic findin
gs at the time of operation (n = 21).
Results: MRI identified the primary breast lesion in 28 of 40 women (70%).
Of these 28 patients, 11 had MRM, 11 had lumpectomy/axillary lymph node dis
section (ALND)/radiotherapy (XRT), 2 had ALND/XRT alone, and 4 had no local
treatment secondary to stage IV disease. Two women initially treated with
lumpectomy/ALND subsequently had mastectomy for positive margins. Of the wo
men with positive MRI who had breast surgery, 21 of 22 (95%) had tumor with
in the surgical specimen. Twelve women had negative MRI of the breast. Five
of these 12 underwent MRM, of whom 4 had no tumor in the mastectomy specim
en. The remaining 7 patients had ALND and whole breast radiation (ALND/XRT)
(n = 5), or were observed (n = 2). Overall, 18 of 34 women surgically trea
ted had MRM, while 16 (47%) preserved their breast. Tumor yield for patient
s having breast surgery was 81%.
Conclusions: MRI of the breast can identify occult breast cancer in many pa
tients and may facilitate breast conservation in select women. Negative bre
ast MRI predicts low tumor yield at mastectomy.